

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 7.65106642 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 7.65106642 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.73931362 |
| 4 | protein retention in ER lumen (GO:0006621) | 4.39505513 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.19663323 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.19663323 |
| 7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.18855646 |
| 8 | epithelial cell fate commitment (GO:0072148) | 4.02928274 |
| 9 | apoptotic cell clearance (GO:0043277) | 3.72273950 |
| 10 | pinocytosis (GO:0006907) | 3.67087312 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.66788330 |
| 12 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.60282800 |
| 13 | positive regulation of nuclease activity (GO:0032075) | 3.44642634 |
| 14 | barbed-end actin filament capping (GO:0051016) | 3.44341132 |
| 15 | exocrine pancreas development (GO:0031017) | 3.37147222 |
| 16 | vesicle coating (GO:0006901) | 3.33814064 |
| 17 | sequestering of metal ion (GO:0051238) | 3.33725550 |
| 18 | axon extension involved in axon guidance (GO:0048846) | 3.30333890 |
| 19 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.30333890 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.23989769 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.23989769 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.23989769 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.23989769 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.23989769 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.23989769 |
| 26 | COPII vesicle coating (GO:0048208) | 3.19660468 |
| 27 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.16610966 |
| 28 | glucose 6-phosphate metabolic process (GO:0051156) | 3.16021118 |
| 29 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.14438772 |
| 30 | protein localization to endosome (GO:0036010) | 3.14029443 |
| 31 | regulation of nuclease activity (GO:0032069) | 3.11036744 |
| 32 | stress fiber assembly (GO:0043149) | 3.05250307 |
| 33 | cellular response to unfolded protein (GO:0034620) | 3.04546274 |
| 34 | cellular copper ion homeostasis (GO:0006878) | 3.04044680 |
| 35 | negative regulation of fatty acid transport (GO:2000192) | 3.03777236 |
| 36 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.02398506 |
| 37 | chondrocyte proliferation (GO:0035988) | 2.97680514 |
| 38 | ER-nucleus signaling pathway (GO:0006984) | 2.97511949 |
| 39 | response to laminar fluid shear stress (GO:0034616) | 2.97246685 |
| 40 | glycosphingolipid catabolic process (GO:0046479) | 2.94164406 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 2.92048424 |
| 42 | cellular response to topologically incorrect protein (GO:0035967) | 2.89183469 |
| 43 | positive regulation of extracellular matrix organization (GO:1903055) | 2.88933114 |
| 44 | peptide catabolic process (GO:0043171) | 2.88601028 |
| 45 | regulation of apoptotic cell clearance (GO:2000425) | 2.85374598 |
| 46 | * membrane protein ectodomain proteolysis (GO:0006509) | 2.82224783 |
| 47 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80144245 |
| 48 | protein carboxylation (GO:0018214) | 2.79071194 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.79071194 |
| 50 | lung epithelium development (GO:0060428) | 2.76824977 |
| 51 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.76754307 |
| 52 | signal peptide processing (GO:0006465) | 2.76168770 |
| 53 | peptidyl-proline hydroxylation (GO:0019511) | 2.75535549 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73059416 |
| 55 | keratan sulfate catabolic process (GO:0042340) | 2.71910340 |
| 56 | mannose metabolic process (GO:0006013) | 2.69665196 |
| 57 | adhesion of symbiont to host (GO:0044406) | 2.69216445 |
| 58 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.68773718 |
| 59 | negative regulation of fibrinolysis (GO:0051918) | 2.67462955 |
| 60 | protein maturation by protein folding (GO:0022417) | 2.66279613 |
| 61 | glycolipid catabolic process (GO:0019377) | 2.65638963 |
| 62 | protein hydroxylation (GO:0018126) | 2.65454366 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.65176210 |
| 64 | cell adhesion mediated by integrin (GO:0033627) | 2.65044030 |
| 65 | venous blood vessel morphogenesis (GO:0048845) | 2.64754137 |
| 66 | hemidesmosome assembly (GO:0031581) | 2.60247238 |
| 67 | fibril organization (GO:0097435) | 2.59846473 |
| 68 | negative regulation of protein activation cascade (GO:2000258) | 2.59414979 |
| 69 | negative regulation of complement activation (GO:0045916) | 2.57956433 |
| 70 | NADPH regeneration (GO:0006740) | 2.55499479 |
| 71 | skin morphogenesis (GO:0043589) | 2.54945204 |
| 72 | response to endoplasmic reticulum stress (GO:0034976) | 2.54806923 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.53773941 |
| 74 | basement membrane organization (GO:0071711) | 2.53007019 |
| 75 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.52793564 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 2.52731992 |
| 77 | virion attachment to host cell (GO:0019062) | 2.52731992 |
| 78 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.51867909 |
| 79 | regulation of cholesterol homeostasis (GO:2000188) | 2.51734254 |
| 80 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.50681231 |
| 81 | endodermal cell differentiation (GO:0035987) | 2.50020244 |
| 82 | collagen metabolic process (GO:0032963) | 2.48995349 |
| 83 | extracellular fibril organization (GO:0043206) | 2.48536660 |
| 84 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.47369982 |
| 85 | macrophage activation involved in immune response (GO:0002281) | 2.47166773 |
| 86 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.46322750 |
| 87 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.46288901 |
| 88 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.46062155 |
| 89 | platelet degranulation (GO:0002576) | 2.45191685 |
| 90 | regulation of complement activation (GO:0030449) | 2.44825976 |
| 91 | positive regulation of receptor recycling (GO:0001921) | 2.44677367 |
| 92 | regulation of extracellular matrix disassembly (GO:0010715) | 2.44465993 |
| 93 | regulation of protein activation cascade (GO:2000257) | 2.43519060 |
| 94 | 4-hydroxyproline metabolic process (GO:0019471) | 2.43114831 |
| 95 | response to thyroid hormone (GO:0097066) | 2.42334595 |
| 96 | response to muramyl dipeptide (GO:0032495) | 2.41740883 |
| 97 | collagen fibril organization (GO:0030199) | 2.41568026 |
| 98 | response to host (GO:0075136) | 2.39866454 |
| 99 | response to host defenses (GO:0052200) | 2.39866454 |
| 100 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.39866454 |
| 101 | cellular response to vitamin D (GO:0071305) | 2.39860567 |
| 102 | * extracellular matrix disassembly (GO:0022617) | 2.39607780 |
| 103 | oligosaccharide catabolic process (GO:0009313) | 2.39345498 |
| 104 | collagen catabolic process (GO:0030574) | 2.37862778 |
| 105 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.36565325 |
| 106 | cellular response to vitamin (GO:0071295) | 2.36409418 |
| 107 | semaphorin-plexin signaling pathway (GO:0071526) | 2.36314461 |
| 108 | negative regulation of humoral immune response (GO:0002921) | 2.35565708 |
| 109 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.35048623 |
| 110 | glandular epithelial cell development (GO:0002068) | 2.34484653 |
| 111 | L-serine transport (GO:0015825) | 2.34104015 |
| 112 | peptidyl-asparagine modification (GO:0018196) | 2.33710004 |
| 113 | type B pancreatic cell proliferation (GO:0044342) | 2.33379704 |
| 114 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.32501526 |
| 115 | endocardial cushion morphogenesis (GO:0003203) | 2.32094963 |
| 116 | cell-substrate junction assembly (GO:0007044) | 2.31923618 |
| 117 | wound healing, spreading of epidermal cells (GO:0035313) | 2.30581773 |
| 118 | glucose catabolic process (GO:0006007) | 2.29972009 |
| 119 | type B pancreatic cell development (GO:0003323) | 2.29774702 |
| 120 | atrioventricular valve morphogenesis (GO:0003181) | 2.29640012 |
| 121 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.29577204 |
| 122 | cellular response to nutrient (GO:0031670) | 2.29359409 |
| 123 | embryo implantation (GO:0007566) | 2.29175986 |
| 124 | positive regulation of phagocytosis (GO:0050766) | 2.29133248 |
| 125 | hyaluronan catabolic process (GO:0030214) | 2.28808205 |
| 126 | muscle cell migration (GO:0014812) | 2.28341250 |
| 127 | plasma lipoprotein particle assembly (GO:0034377) | 2.27704798 |
| 128 | amino sugar catabolic process (GO:0046348) | 2.27590819 |
| 129 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.27244592 |
| 130 | Notch signaling involved in heart development (GO:0061314) | 2.27012842 |
| 131 | growth hormone receptor signaling pathway (GO:0060396) | 2.25893576 |
| 132 | macroautophagy (GO:0016236) | 2.25590835 |
| 133 | substrate-dependent cell migration (GO:0006929) | 2.25519614 |
| 134 | germ cell migration (GO:0008354) | 2.24996524 |
| 135 | detection of molecule of bacterial origin (GO:0032490) | 2.24918895 |
| 136 | multicellular organismal catabolic process (GO:0044243) | 2.24759154 |
| 137 | decidualization (GO:0046697) | 2.24327399 |
| 138 | serine transport (GO:0032329) | 2.24000529 |
| 139 | positive regulation of histone deacetylation (GO:0031065) | 2.23728354 |
| 140 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.23463654 |
| 141 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.22948576 |
| 142 | wound healing, spreading of cells (GO:0044319) | 2.22888871 |
| 143 | protein-lipid complex assembly (GO:0065005) | 2.22263231 |
| 144 | actin nucleation (GO:0045010) | 2.22048226 |
| 145 | regulation of cholesterol storage (GO:0010885) | 2.21297206 |
| 146 | response to unfolded protein (GO:0006986) | 2.20884809 |
| 147 | positive regulation of p38MAPK cascade (GO:1900745) | 2.20655477 |
| 148 | regulation of extracellular matrix organization (GO:1903053) | 2.17339661 |
| 149 | negative regulation of osteoblast proliferation (GO:0033689) | 2.17205106 |
| 150 | low-density lipoprotein particle clearance (GO:0034383) | 2.16816829 |
| 151 | apoptotic process involved in morphogenesis (GO:0060561) | 2.16290771 |
| 152 | positive regulation of interferon-alpha production (GO:0032727) | 2.16121772 |
| 153 | epithelial cell-cell adhesion (GO:0090136) | 2.16084914 |
| 154 | negative regulation of cell size (GO:0045792) | 2.15793011 |
| 155 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.15787522 |
| 156 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.15324555 |
| 157 | peptide hormone processing (GO:0016486) | 2.14229086 |
| 158 | fibroblast migration (GO:0010761) | 2.13399288 |
| 159 | response to topologically incorrect protein (GO:0035966) | 2.12775124 |
| 160 | protein N-linked glycosylation (GO:0006487) | 2.09549306 |
| 161 | coronary vasculature morphogenesis (GO:0060977) | 2.09348076 |
| 162 | pentose-phosphate shunt (GO:0006098) | 2.08850815 |
| 163 | astrocyte differentiation (GO:0048708) | 2.07890465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.48610108 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.03103073 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.45907346 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01633453 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.93059751 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.88195505 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.71720698 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51198276 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.30878244 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26624826 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15860094 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12476717 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12269418 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.11916047 |
| 15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.09430417 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08293976 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.04819842 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.01622105 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.01573296 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94395823 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89571986 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85665831 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82765377 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80993642 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.79843164 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79447867 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75365727 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65947427 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63404425 |
| 30 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.61412602 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60678193 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59653163 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59598920 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56904168 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56705230 |
| 36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56327426 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54134796 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53833293 |
| 39 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.51387504 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51036183 |
| 41 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.50210897 |
| 42 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.49329106 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47562388 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.47015259 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46448231 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44749225 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.41949702 |
| 48 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.41022848 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.38995021 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37367323 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.37270805 |
| 52 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36272589 |
| 53 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.33946822 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33092328 |
| 55 | * MYB_26560356_Chip-Seq_TH2_Human | 1.32665439 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32570600 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31588293 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.31552485 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30582157 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30340827 |
| 61 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30253505 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27957483 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.27874879 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27621151 |
| 65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26964058 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26572651 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25272435 |
| 68 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24998467 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24481381 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24033600 |
| 71 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23967949 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23016455 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21701672 |
| 74 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.20635592 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20514689 |
| 76 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20038319 |
| 77 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.18873458 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18232157 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17674508 |
| 80 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16647598 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15437794 |
| 82 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15248767 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14704891 |
| 84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14409897 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14127777 |
| 86 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14001521 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.11407771 |
| 88 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11258172 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09576404 |
| 90 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09510262 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08867870 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08583427 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08317418 |
| 94 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07545966 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07156016 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05723657 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05311111 |
| 98 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05286698 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04644661 |
| 100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04388998 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02096682 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02096682 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01515412 |
| 104 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00562537 |
| 105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00383505 |
| 106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00065518 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99881025 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99860366 |
| 109 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99854483 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99848207 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99680149 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99620043 |
| 113 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.99439789 |
| 114 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99069484 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98452575 |
| 116 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98452575 |
| 117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97973613 |
| 118 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97674071 |
| 119 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97496644 |
| 120 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97353223 |
| 121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97240750 |
| 122 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96680941 |
| 123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96589442 |
| 124 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96550184 |
| 125 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96421403 |
| 126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96055947 |
| 127 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95426392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.71047906 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.23022016 |
| 3 | MP0006054_spinal_hemorrhage | 3.09014507 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 2.92727739 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.89508622 |
| 6 | MP0005451_abnormal_body_composition | 2.63924296 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.54242129 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.53017713 |
| 9 | MP0010030_abnormal_orbit_morphology | 2.29201056 |
| 10 | MP0008260_abnormal_autophagy | 2.16127420 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.12580295 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.09532798 |
| 13 | MP0001958_emphysema | 2.06213658 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.01569700 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 1.96258101 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 1.96064249 |
| 17 | MP0005275_abnormal_skin_tensile | 1.95109038 |
| 18 | MP0004858_abnormal_nervous_system | 1.93627124 |
| 19 | MP0003436_decreased_susceptibility_to | 1.93120916 |
| 20 | MP0000566_synostosis | 1.83836127 |
| 21 | MP0001533_abnormal_skeleton_physiology | 1.72982724 |
| 22 | MP0003329_amyloid_beta_deposits | 1.69732875 |
| 23 | MP0004272_abnormal_basement_membrane | 1.67473413 |
| 24 | MP0003303_peritoneal_inflammation | 1.67334312 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.64701216 |
| 26 | MP0003283_abnormal_digestive_organ | 1.62247622 |
| 27 | MP0003279_aneurysm | 1.62144924 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.51820719 |
| 29 | MP0005076_abnormal_cell_differentiation | 1.47624403 |
| 30 | MP0004947_skin_inflammation | 1.46584007 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.45805912 |
| 32 | MP0005220_abnormal_exocrine_pancreas | 1.44657123 |
| 33 | MP0009278_abnormal_bone_marrow | 1.44051905 |
| 34 | MP0005023_abnormal_wound_healing | 1.43767056 |
| 35 | * MP0003183_abnormal_peptide_metabolism | 1.42688211 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.42316688 |
| 37 | MP0005365_abnormal_bile_salt | 1.37475812 |
| 38 | MP0005164_abnormal_response_to | 1.30613004 |
| 39 | MP0009840_abnormal_foam_cell | 1.29999285 |
| 40 | MP0003075_altered_response_to | 1.29720511 |
| 41 | MP0002419_abnormal_innate_immunity | 1.29690651 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.29076144 |
| 43 | MP0005390_skeleton_phenotype | 1.24745759 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.24469884 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.23214333 |
| 46 | MP0000858_altered_metastatic_potential | 1.21967717 |
| 47 | MP0001835_abnormal_antigen_presentation | 1.21578545 |
| 48 | MP0001542_abnormal_bone_strength | 1.20409834 |
| 49 | MP0009384_cardiac_valve_regurgitation | 1.19703085 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.19355685 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.19320780 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.18551201 |
| 53 | MP0000751_myopathy | 1.18367218 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.13779948 |
| 55 | MP0002933_joint_inflammation | 1.13722163 |
| 56 | MP0002089_abnormal_postnatal_growth/wei | 1.12508952 |
| 57 | MP0003091_abnormal_cell_migration | 1.11993452 |
| 58 | MP0006082_CNS_inflammation | 1.10453109 |
| 59 | MP0005508_abnormal_skeleton_morphology | 1.09761470 |
| 60 | MP0000685_abnormal_immune_system | 1.08921741 |
| 61 | MP0002896_abnormal_bone_mineralization | 1.07000254 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.05103090 |
| 63 | MP0003795_abnormal_bone_structure | 1.04398936 |
| 64 | MP0005360_urolithiasis | 1.03364634 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.03351979 |
| 66 | MP0004883_abnormal_blood_vessel | 1.02584080 |
| 67 | MP0001944_abnormal_pancreas_morphology | 1.02078601 |
| 68 | MP0001873_stomach_inflammation | 1.00812091 |
| 69 | MP0003045_fibrosis | 1.00252405 |
| 70 | MP0003115_abnormal_respiratory_system | 0.99823953 |
| 71 | MP0009053_abnormal_anal_canal | 0.99621351 |
| 72 | MP0005409_darkened_coat_color | 0.98713508 |
| 73 | MP0001756_abnormal_urination | 0.98657152 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 0.98272907 |
| 75 | MP0003448_altered_tumor_morphology | 0.96688308 |
| 76 | MP0002909_abnormal_adrenal_gland | 0.96580952 |
| 77 | MP0002060_abnormal_skin_morphology | 0.94737090 |
| 78 | MP0000343_altered_response_to | 0.94239654 |
| 79 | MP0001243_abnormal_dermal_layer | 0.94230305 |
| 80 | MP0005000_abnormal_immune_tolerance | 0.93677982 |
| 81 | MP0000767_abnormal_smooth_muscle | 0.92248689 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 0.92155772 |
| 83 | MP0001849_ear_inflammation | 0.91675703 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.91459657 |
| 85 | MP0000920_abnormal_myelination | 0.91167742 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.90960687 |
| 87 | MP0001845_abnormal_inflammatory_respons | 0.90535350 |
| 88 | MP0000733_abnormal_muscle_development | 0.89930054 |
| 89 | MP0000678_abnormal_parathyroid_gland | 0.88952066 |
| 90 | MP0002234_abnormal_pharynx_morphology | 0.88673506 |
| 91 | MP0000538_abnormal_urinary_bladder | 0.88257135 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.87908870 |
| 93 | MP0002006_tumorigenesis | 0.87631923 |
| 94 | MP0000371_diluted_coat_color | 0.87157354 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.87109523 |
| 96 | MP0005025_abnormal_response_to | 0.86980154 |
| 97 | MP0001661_extended_life_span | 0.86687653 |
| 98 | MP0004134_abnormal_chest_morphology | 0.86555573 |
| 99 | MP0002405_respiratory_system_inflammati | 0.85832550 |
| 100 | MP0005165_increased_susceptibility_to | 0.84576692 |
| 101 | MP0003724_increased_susceptibility_to | 0.84076187 |
| 102 | MP0005408_hypopigmentation | 0.84028623 |
| 103 | MP0005310_abnormal_salivary_gland | 0.83823730 |
| 104 | MP0000604_amyloidosis | 0.83702136 |
| 105 | MP0001915_intracranial_hemorrhage | 0.83364155 |
| 106 | MP0004808_abnormal_hematopoietic_stem | 0.83201519 |
| 107 | MP0010329_abnormal_lipoprotein_level | 0.83103881 |
| 108 | MP0005387_immune_system_phenotype | 0.81388978 |
| 109 | MP0001790_abnormal_immune_system | 0.81388978 |
| 110 | MP0009785_altered_susceptibility_to | 0.80691286 |
| 111 | MP0000163_abnormal_cartilage_morphology | 0.80074307 |
| 112 | MP0003690_abnormal_glial_cell | 0.79839078 |
| 113 | MP0008469_abnormal_protein_level | 0.79444383 |
| 114 | MP0000428_abnormal_craniofacial_morphol | 0.79178255 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.78463633 |
| 116 | MP0003828_pulmonary_edema | 0.78151478 |
| 117 | MP0002148_abnormal_hypersensitivity_rea | 0.76486512 |
| 118 | MP0000249_abnormal_blood_vessel | 0.76057903 |
| 119 | MP0002113_abnormal_skeleton_development | 0.75813075 |
| 120 | MP0004233_abnormal_muscle_weight | 0.74922901 |
| 121 | MP0000490_abnormal_crypts_of | 0.74657672 |
| 122 | MP0002132_abnormal_respiratory_system | 0.74224882 |
| 123 | MP0001666_abnormal_nutrient_absorption | 0.73963361 |
| 124 | MP0002135_abnormal_kidney_morphology | 0.73569083 |
| 125 | * MP0001614_abnormal_blood_vessel | 0.72407766 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.72336492 |
| 127 | MP0003942_abnormal_urinary_system | 0.71807163 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.71591863 |
| 129 | MP0003122_maternal_imprinting | 0.70154499 |
| 130 | MP0005621_abnormal_cell_physiology | 0.70023140 |
| 131 | MP0005248_abnormal_Harderian_gland | 0.69514899 |
| 132 | MP0005197_abnormal_uvea_morphology | 0.69414034 |
| 133 | MP0005171_absent_coat_pigmentation | 0.69199497 |
| 134 | MP0003656_abnormal_erythrocyte_physiolo | 0.68078271 |
| 135 | MP0000609_abnormal_liver_physiology | 0.68044469 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.66452009 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.66286009 |
| 138 | MP0005397_hematopoietic_system_phenotyp | 0.66286009 |
| 139 | * MP0003634_abnormal_glial_cell | 0.65229287 |
| 140 | MP0005085_abnormal_gallbladder_physiolo | 0.64512866 |
| 141 | MP0009763_increased_sensitivity_to | 0.64474742 |
| 142 | MP0000681_abnormal_thyroid_gland | 0.64348236 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.63276832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dysostosis multiplex (HP:0000943) | 3.96696287 |
| 2 | Protrusio acetabuli (HP:0003179) | 3.70268689 |
| 3 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.69475467 |
| 4 | Mucopolysacchariduria (HP:0008155) | 3.69475467 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.58343948 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.51346419 |
| 7 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.51072084 |
| 8 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.51072084 |
| 9 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.51072084 |
| 10 | Aortic aneurysm (HP:0004942) | 3.38443239 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.30666512 |
| 12 | Cervical subluxation (HP:0003308) | 3.13733237 |
| 13 | Deep venous thrombosis (HP:0002625) | 3.10453250 |
| 14 | Aortic dissection (HP:0002647) | 3.01388411 |
| 15 | Spondylolisthesis (HP:0003302) | 2.98524639 |
| 16 | Arterial tortuosity (HP:0005116) | 2.81551739 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.80884747 |
| 18 | Hand muscle atrophy (HP:0009130) | 2.80080782 |
| 19 | Vascular tortuosity (HP:0004948) | 2.71442575 |
| 20 | Premature rupture of membranes (HP:0001788) | 2.69035582 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68478796 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68478796 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68478796 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 2.61410041 |
| 25 | Aneurysm (HP:0002617) | 2.60924640 |
| 26 | Striae distensae (HP:0001065) | 2.56725295 |
| 27 | Vertebral compression fractures (HP:0002953) | 2.54216887 |
| 28 | Amyloidosis (HP:0011034) | 2.53177281 |
| 29 | Myocardial infarction (HP:0001658) | 2.43870194 |
| 30 | Severe short stature (HP:0003510) | 2.40695827 |
| 31 | Thin bony cortex (HP:0002753) | 2.38167429 |
| 32 | Shallow orbits (HP:0000586) | 2.35063449 |
| 33 | Abnormality of macrophages (HP:0004311) | 2.34749214 |
| 34 | Eczematoid dermatitis (HP:0000976) | 2.33882471 |
| 35 | Neurofibrillary tangles (HP:0002185) | 2.33682849 |
| 36 | Peritonitis (HP:0002586) | 2.33044398 |
| 37 | Short nail (HP:0001799) | 2.32702195 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.27173035 |
| 39 | Periodontitis (HP:0000704) | 2.25228805 |
| 40 | Biconcave vertebral bodies (HP:0004586) | 2.24895273 |
| 41 | Distal upper limb amyotrophy (HP:0007149) | 2.23822384 |
| 42 | Upper limb amyotrophy (HP:0009129) | 2.23822384 |
| 43 | Long toe (HP:0010511) | 2.23684125 |
| 44 | Abnormality of complement system (HP:0005339) | 2.23354406 |
| 45 | Dilatation of the ascending aorta (HP:0005111) | 2.19739713 |
| 46 | Flat acetabular roof (HP:0003180) | 2.18219055 |
| 47 | Neonatal short-limb short stature (HP:0008921) | 2.17317364 |
| 48 | Atrophic scars (HP:0001075) | 2.16545079 |
| 49 | Complement deficiency (HP:0004431) | 2.13472475 |
| 50 | Upper motor neuron abnormality (HP:0002127) | 2.13081135 |
| 51 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.12659695 |
| 52 | Cholecystitis (HP:0001082) | 2.07171249 |
| 53 | Abnormal gallbladder physiology (HP:0012438) | 2.07171249 |
| 54 | Bladder diverticulum (HP:0000015) | 2.06901449 |
| 55 | Abnormality of the lumbar spine (HP:0100712) | 2.06687390 |
| 56 | Abnormality of the acetabulum (HP:0003170) | 2.06563534 |
| 57 | Follicular hyperkeratosis (HP:0007502) | 2.03413752 |
| 58 | Nuclear cataract (HP:0100018) | 2.00585677 |
| 59 | Asymmetric septal hypertrophy (HP:0001670) | 1.99399081 |
| 60 | Camptodactyly of toe (HP:0001836) | 1.98886325 |
| 61 | Spinal rigidity (HP:0003306) | 1.98649232 |
| 62 | Abnormality of skull ossification (HP:0002703) | 1.97967953 |
| 63 | Recurrent abscess formation (HP:0002722) | 1.97337872 |
| 64 | Cardiovascular calcification (HP:0011915) | 1.94676002 |
| 65 | Broad face (HP:0000283) | 1.94294691 |
| 66 | Abnormal delivery (HP:0001787) | 1.92808418 |
| 67 | Soft skin (HP:0000977) | 1.91220312 |
| 68 | Hemorrhage of the eye (HP:0011885) | 1.91103962 |
| 69 | Ankle contracture (HP:0006466) | 1.89391877 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89376385 |
| 71 | Neonatal death (HP:0003811) | 1.86996774 |
| 72 | Coxa vara (HP:0002812) | 1.86827787 |
| 73 | Joint stiffness (HP:0001387) | 1.85861336 |
| 74 | Esophageal varix (HP:0002040) | 1.85720020 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 1.85640537 |
| 76 | Xanthomatosis (HP:0000991) | 1.85295429 |
| 77 | Nonimmune hydrops fetalis (HP:0001790) | 1.84566802 |
| 78 | Purpura (HP:0000979) | 1.84329114 |
| 79 | Cerebral inclusion bodies (HP:0100314) | 1.84038007 |
| 80 | Joint laxity (HP:0001388) | 1.82316945 |
| 81 | Abnormality of the right ventricle (HP:0001707) | 1.81653591 |
| 82 | Hematochezia (HP:0002573) | 1.78410337 |
| 83 | Hypercortisolism (HP:0001578) | 1.78283930 |
| 84 | Retinal atrophy (HP:0001105) | 1.77622882 |
| 85 | Abnormality of the Achilles tendon (HP:0005109) | 1.77030174 |
| 86 | Glomerulonephritis (HP:0000099) | 1.76351576 |
| 87 | Blue sclerae (HP:0000592) | 1.76176908 |
| 88 | Disproportionate short-trunk short stature (HP:0003521) | 1.76066859 |
| 89 | Mitral stenosis (HP:0001718) | 1.75870865 |
| 90 | J-shaped sella turcica (HP:0002680) | 1.75756501 |
| 91 | Pathologic fracture (HP:0002756) | 1.75554732 |
| 92 | Broad metatarsal (HP:0001783) | 1.75119029 |
| 93 | Osteopenia (HP:0000938) | 1.75117011 |
| 94 | Platyspondyly (HP:0000926) | 1.74943083 |
| 95 | Abnormality of the common coagulation pathway (HP:0010990) | 1.74825597 |
| 96 | Joint hemorrhage (HP:0005261) | 1.74100794 |
| 97 | Abnormality of dentin (HP:0010299) | 1.73569589 |
| 98 | Vascular calcification (HP:0004934) | 1.73524620 |
| 99 | Gingival bleeding (HP:0000225) | 1.73216413 |
| 100 | Polycythemia (HP:0001901) | 1.72901434 |
| 101 | Back pain (HP:0003418) | 1.72841791 |
| 102 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.72648849 |
| 103 | Beaking of vertebral bodies (HP:0004568) | 1.72485369 |
| 104 | Abnormality of carpal bone ossification (HP:0006257) | 1.71868389 |
| 105 | Achilles tendon contracture (HP:0001771) | 1.71572769 |
| 106 | Increased connective tissue (HP:0009025) | 1.71462425 |
| 107 | Spinal canal stenosis (HP:0003416) | 1.71117675 |
| 108 | Hypercholesterolemia (HP:0003124) | 1.71067850 |
| 109 | Exostoses (HP:0100777) | 1.71044274 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.70766317 |
| 111 | Osteoarthritis (HP:0002758) | 1.70122637 |
| 112 | Hyperextensible skin (HP:0000974) | 1.70012596 |
| 113 | Cardiomegaly (HP:0001640) | 1.70007184 |
| 114 | Growth hormone excess (HP:0000845) | 1.69825810 |
| 115 | Fragile skin (HP:0001030) | 1.69607600 |
| 116 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.69483682 |
| 117 | Cupped ribs (HP:0000887) | 1.69351320 |
| 118 | Abnormality of the odontoid process (HP:0003310) | 1.68887526 |
| 119 | Gingivitis (HP:0000230) | 1.68818643 |
| 120 | Myositis (HP:0100614) | 1.67748276 |
| 121 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.66764110 |
| 122 | Abnormality of the anterior horn cell (HP:0006802) | 1.66686065 |
| 123 | Degeneration of anterior horn cells (HP:0002398) | 1.66686065 |
| 124 | Recurrent bacterial skin infections (HP:0005406) | 1.66676345 |
| 125 | Genu recurvatum (HP:0002816) | 1.66315822 |
| 126 | Skin nodule (HP:0200036) | 1.65131202 |
| 127 | Autoimmune thrombocytopenia (HP:0001973) | 1.65010702 |
| 128 | Increased density of long bones (HP:0006392) | 1.64919737 |
| 129 | Hallux valgus (HP:0001822) | 1.64116023 |
| 130 | Congenital glaucoma (HP:0001087) | 1.63947701 |
| 131 | Abnormal ossification of hand bones (HP:0005921) | 1.63934666 |
| 132 | Spinal muscular atrophy (HP:0007269) | 1.63744327 |
| 133 | Mitral valve prolapse (HP:0001634) | 1.63313896 |
| 134 | Abnormality of the peritoneum (HP:0002585) | 1.63197509 |
| 135 | Protuberant abdomen (HP:0001538) | 1.63123447 |
| 136 | Wormian bones (HP:0002645) | 1.62942131 |
| 137 | Progressive neurologic deterioration (HP:0002344) | 1.62610138 |
| 138 | Deviation of the hallux (HP:0010051) | 1.62224747 |
| 139 | Lymphangioma (HP:0100764) | 1.61303086 |
| 140 | Disproportionate tall stature (HP:0001519) | 1.60525533 |
| 141 | Hypoglycemic seizures (HP:0002173) | 1.59170778 |
| 142 | Bicuspid aortic valve (HP:0001647) | 1.58224882 |
| 143 | Ovoid vertebral bodies (HP:0003300) | 1.57878075 |
| 144 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.56485728 |
| 145 | Joint contractures involving the joints of the feet (HP:0100492) | 1.55259553 |
| 146 | Flexion contracture of toe (HP:0005830) | 1.55259553 |
| 147 | Osteolytic defects of the hand bones (HP:0009699) | 1.54982450 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.54982450 |
| 149 | Loss of speech (HP:0002371) | 1.54355022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.85969153 |
| 2 | TRIB3 | 3.70941084 |
| 3 | EPHA3 | 3.03510064 |
| 4 | PKN2 | 2.58872676 |
| 5 | PRPF4B | 2.19272778 |
| 6 | SIK1 | 2.19131677 |
| 7 | TESK1 | 2.10756798 |
| 8 | FGFR3 | 2.05368470 |
| 9 | PTK6 | 2.00100541 |
| 10 | RIPK1 | 1.97093282 |
| 11 | MAP3K10 | 1.94485036 |
| 12 | FGFR4 | 1.90360671 |
| 13 | ICK | 1.82180748 |
| 14 | MAPK15 | 1.80276338 |
| 15 | NTRK1 | 1.80236389 |
| 16 | TGFBR2 | 1.77418636 |
| 17 | TBK1 | 1.76736688 |
| 18 | PDGFRA | 1.72867587 |
| 19 | PIK3CG | 1.68428539 |
| 20 | TTN | 1.67926183 |
| 21 | MET | 1.58363937 |
| 22 | PAK4 | 1.57892079 |
| 23 | MST1R | 1.54828043 |
| 24 | SIK3 | 1.45914047 |
| 25 | EEF2K | 1.44679200 |
| 26 | EPHB2 | 1.44451247 |
| 27 | FLT3 | 1.40675775 |
| 28 | MOS | 1.39933541 |
| 29 | ZAP70 | 1.38849408 |
| 30 | TYK2 | 1.36533403 |
| 31 | SMG1 | 1.34698069 |
| 32 | KSR2 | 1.33901244 |
| 33 | LRRK2 | 1.33823475 |
| 34 | PRKD2 | 1.29116465 |
| 35 | PASK | 1.28626162 |
| 36 | PTK2 | 1.28139650 |
| 37 | EPHB1 | 1.26346394 |
| 38 | EPHA2 | 1.22398338 |
| 39 | IRAK3 | 1.22116051 |
| 40 | TAOK3 | 1.20992239 |
| 41 | STK10 | 1.18541728 |
| 42 | MAP3K6 | 1.18205864 |
| 43 | KIT | 1.18091964 |
| 44 | JAK3 | 1.15760277 |
| 45 | MAP4K1 | 1.15599281 |
| 46 | JAK1 | 1.13327014 |
| 47 | INSRR | 1.12582306 |
| 48 | ARAF | 1.10304981 |
| 49 | FGFR1 | 1.07119132 |
| 50 | DYRK1B | 1.05568471 |
| 51 | CDK12 | 1.04029293 |
| 52 | IRAK4 | 1.02803155 |
| 53 | TGFBR1 | 1.01642334 |
| 54 | FER | 0.99784965 |
| 55 | TESK2 | 0.96839337 |
| 56 | LMTK2 | 0.96632373 |
| 57 | CHUK | 0.93197147 |
| 58 | MAP3K3 | 0.91109632 |
| 59 | FGR | 0.90853771 |
| 60 | ERBB3 | 0.90302228 |
| 61 | BTK | 0.88594463 |
| 62 | MAP3K1 | 0.88401379 |
| 63 | SCYL2 | 0.88384931 |
| 64 | ITK | 0.86458728 |
| 65 | TAOK2 | 0.86223005 |
| 66 | LIMK1 | 0.85646876 |
| 67 | RIPK4 | 0.85634651 |
| 68 | KDR | 0.83623341 |
| 69 | LATS1 | 0.83010980 |
| 70 | RPS6KA4 | 0.81474427 |
| 71 | CAMK1D | 0.81195995 |
| 72 | RPS6KA2 | 0.81145608 |
| 73 | MAP2K3 | 0.80928524 |
| 74 | MAPKAPK3 | 0.80532032 |
| 75 | BLK | 0.79225697 |
| 76 | MAPK7 | 0.78547158 |
| 77 | CSK | 0.78036479 |
| 78 | DDR2 | 0.77473876 |
| 79 | PDPK1 | 0.76551182 |
| 80 | MAP3K13 | 0.75715564 |
| 81 | MAP3K11 | 0.75182936 |
| 82 | MTOR | 0.74225176 |
| 83 | IKBKE | 0.73808413 |
| 84 | PAK3 | 0.73789171 |
| 85 | CSF1R | 0.73782660 |
| 86 | MAP3K14 | 0.73612991 |
| 87 | BRD4 | 0.73374947 |
| 88 | NEK9 | 0.73106623 |
| 89 | FRK | 0.72820914 |
| 90 | HIPK2 | 0.71875148 |
| 91 | STK38 | 0.71596153 |
| 92 | ERBB2 | 0.69644459 |
| 93 | JAK2 | 0.66333991 |
| 94 | BMX | 0.65490949 |
| 95 | MAP3K2 | 0.65407545 |
| 96 | PRKG2 | 0.64391037 |
| 97 | PDK2 | 0.63346131 |
| 98 | MAPK11 | 0.63103139 |
| 99 | PAK2 | 0.60376486 |
| 100 | CLK1 | 0.60133389 |
| 101 | PRKCH | 0.59549539 |
| 102 | ROCK2 | 0.57230371 |
| 103 | MYLK | 0.56934468 |
| 104 | MAP3K5 | 0.56848568 |
| 105 | GRK7 | 0.56830492 |
| 106 | PIM2 | 0.56387359 |
| 107 | CDK6 | 0.55105610 |
| 108 | MAP2K2 | 0.55021786 |
| 109 | PDGFRB | 0.54603238 |
| 110 | MAPKAPK2 | 0.52392206 |
| 111 | BUB1 | 0.52122575 |
| 112 | DMPK | 0.51901868 |
| 113 | KSR1 | 0.51424459 |
| 114 | WNK3 | 0.50421142 |
| 115 | PRKD3 | 0.49197225 |
| 116 | RPS6KA6 | 0.48393641 |
| 117 | RPS6KC1 | 0.48339708 |
| 118 | RPS6KL1 | 0.48339708 |
| 119 | YES1 | 0.47312907 |
| 120 | ERBB4 | 0.47283138 |
| 121 | GRK6 | 0.46978734 |
| 122 | CDC42BPA | 0.46695398 |
| 123 | NME2 | 0.46592285 |
| 124 | MAP2K1 | 0.46257984 |
| 125 | SRC | 0.45778765 |
| 126 | IRAK1 | 0.45758972 |
| 127 | CDK8 | 0.44958932 |
| 128 | CAMK1G | 0.43635325 |
| 129 | MARK2 | 0.42712229 |
| 130 | MATK | 0.42255671 |
| 131 | TRPM7 | 0.41546046 |
| 132 | ROCK1 | 0.41197849 |
| 133 | RET | 0.40187405 |
| 134 | ILK | 0.40185428 |
| 135 | PRKD1 | 0.39967459 |
| 136 | IGF1R | 0.39636943 |
| 137 | LATS2 | 0.38585251 |
| 138 | FYN | 0.36171951 |
| 139 | MAP3K8 | 0.35829352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.79996543 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.70200370 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.44576222 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.28842071 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.06307901 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92373933 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.80664691 |
| 8 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.76024635 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 1.63517123 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53721136 |
| 11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.53035670 |
| 12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.47473702 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44337892 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42627236 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40215718 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39477151 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37890386 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36910508 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.33932827 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33438623 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33338481 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32187300 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.29647370 |
| 24 | Bladder cancer_Homo sapiens_hsa05219 | 1.28901051 |
| 25 | * Notch signaling pathway_Homo sapiens_hsa04330 | 1.28225699 |
| 26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.25271017 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.23371725 |
| 28 | Amoebiasis_Homo sapiens_hsa05146 | 1.22946012 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22762576 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.22739931 |
| 31 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.22323061 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.15987665 |
| 33 | Adherens junction_Homo sapiens_hsa04520 | 1.15701502 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14529755 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.13709633 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12696893 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12509300 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12073965 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09228191 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08780303 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.05419656 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05252777 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04732671 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03297973 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.01662219 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 1.01563502 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01478037 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01416627 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01019268 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00139696 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99530622 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 0.98228397 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97511658 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.96431808 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94885425 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.94667789 |
| 57 | Measles_Homo sapiens_hsa05162 | 0.93136593 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92731100 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92549502 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92097998 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91955029 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90553574 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89915477 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88256819 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87328422 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87023808 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.85663952 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85429756 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83011766 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80324722 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79789188 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79114027 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77521655 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73914925 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73751357 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.72883482 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.72777939 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71686504 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.71033992 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70594872 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70373867 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69059333 |
| 83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66911198 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66121530 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65564020 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63758265 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63191007 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62331174 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61720971 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61358422 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61198407 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.60666081 |
| 93 | Protein export_Homo sapiens_hsa03060 | 0.60641628 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60288678 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59862413 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59406235 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59271825 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59046848 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58875321 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58783343 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56753835 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56303675 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56128175 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55582773 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55211145 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55182103 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54077947 |
| 108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52554836 |
| 109 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51899131 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50326294 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49846259 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.49653173 |
| 113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49524859 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48596125 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48268254 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47261425 |
| 117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46928973 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46555270 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46304929 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46298647 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46183712 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45037990 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44840574 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44633415 |
| 125 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43612521 |
| 126 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39857935 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37602493 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35149601 |
| 129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33348097 |

